NCT07294911Completed
Predictors of Contrast-induced Acute Renal Injury in Patients With Acute Coronary Syndrome
Predictors of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndrome
Source: ClinicalTrials.gov · Last updated 19 Dec 2025
Brief summary (registry, in English)
This observational study aims to identify predictors of contrast-induced acute kidney injury (CI-AKI) in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Clinical, laboratory, and procedural factors will be analyzed to determine their association with the development of CI-AKI. The findings may help improve risk stratification and preventive strategies in this high-risk population.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 88 (actual)
- First submitted
- 8 Dec 2025
- Start date
- 2 Nov 2024
- Primary completion date
- 2 Jun 2025
- Lead sponsor
- Karaganda Medical University
- Diseases
- Coronary artery disease
- NCT number
- NCT07294911
What you commit to
- Study type: Observational
- Participants enrolled: 88
- From 2 Nov 2024 to the primary completion date, 2 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Exposure to intravenous contrast within the previous 7 days
- Use of nephrotoxic drugs (e.g., aminoglycosides, amphotericin B) within 72 hours prior to contrast exposure
Other illness
- Hemodynamic instability not related to acute coronary syndrome (e.g., septic shock)
- Active infection or inflammatory disease affecting renal function
Lab values
- Known chronic kidney disease stage 4 or 5 (eGFR \< 30 mL/min/1.73 m²) or on dialysis
Other
- Pregnancy or breastfeeding
- Refusal or inability to provide informed consent
Who the study is looking for
- Age ≥ 18 years
- Diagnosis of acute coronary syndrome (STEMI or NSTEMI) confirmed by clinical, ECG, and laboratory findings
- Undergoing coronary angiography or percutaneous coronary intervention with intravascular contrast administration
- Provided informed consent to participate in the study
- Availability of baseline and follow-up serum creatinine values
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Karaganda Medical University Coordinator of this site? Confirm its status | Karaganda | Kazakhstan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.